Close
Help




JOURNAL

Clinical Medicine Insights: Cardiology

TAVR and SAVR: Current Treatment of Aortic Stenosis

Submit a Paper


Clinical Medicine Insights: Cardiology 2012:6 125-139

Review

Published on 23 Aug 2012

DOI: 10.4137/CMC.S7540


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Clinical Medicine Insights: Cardiology

Abstract

Transcatheter aortic valve replacement (TAVR) was approved in the United States in late 2011, providing a critically needed alternative therapy for patients with severe aortic stenosis previously refused surgical aortic valve replacement (SAVR). Over 20,000 TAVR have been performed in patients worldwide since 2002 when Alain Cribier performed the first-in-man TAVR. This paper reviews the data from balloon expandable and self-expanding aortic stent valves as well as data comparing them with traditional surgical aortic valve replacement (SAVR). Complications using criteria established by the Valve Academic Research Consortium (VARC) are reviewed. Future challenges and possibilities are discussed and will make optimizing TAVR an important goal in the years to come.



Downloads

PDF  (1.12 MB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Clinical Medicine Insights: Cardiology
The review process in Libertas Academica journals is prompt, objective and rigorous.  The entire process is smooth and clear and all the editorial staff are cooperative and professional.  Published papers are of top clinical and scientific value, and high metrics reflect the excellent quality of Libertas Academica's journals.
Dr Antoine Kossaify (USEK NDS University Hospital, Byblos, Lebanon)
More Testimonials

Quick Links


New article and journal news notification services